Environmental Policy

Environmental Policy

Environmental Statement

Founded in 1979 and based in Tredegar, South Wales, Penn Pharma is one of the longest established Pharmaceutical service companies in the UK. Penn’s core business is the provision of a comprehensive clinical trials packaging supplies service, supported by integrated formulation development, analytical development and contract manufacturing facilities.

Penn Pharma recognises that an awareness of the environment and environmental issues relevant to our operations should be a fundamental part of our business. Penn Pharma is committed to its policy of responsible management of the environmental aspects of the business and the minimisation of the impacts these aspects can have on the local, and wider, environment. Penn is accredited to the ISO 14001 international standard for environmental management, and is audited annually by SGS.

Penn has a well developed environmental management system (EMS) that is interlinked with the company’s Health & Safety, Quality and GMP systems. The environmental management strategy is fully embedded within the business model, and is an established element within the training, induction, budgeting and business process framework. Penn reviews its environmental performance on a regular basis and has developed a continuous improvement program to ensure continuity of responsible environmental management as the business grows.

The objectives set for 2009 yielded the following results:

T01/09

Reduction of accidents by 12% - Final achievement= 28% reduction. Near miss reporting was overachieved by an additional 80%, and Occupational Health events were all fully achieved

T02/09

Introduction of e-fax – on hold for technical reasons

T03/09

Acquisition of Low Carbon Status - still in progress

T04/09

Reduction in energy consumption achieved the following reduction against 2008:

  • Electricity 1% reduction
  • Gas 14% reduction
  • Water 19% reduction

T05/09

Reduce waste to landfill - Approximately 3% reduction has been achieved

Monitoring Activities

Status

Packaging Waste Obligations

Penn now a non obligated member of Valpack

WEEE Regulations – monitor implementation plan

A mature and robust segregation system is in place

Non-hazardous waste

Pre-treatment by segregation is in place

REACH

Substance list confirmed and each substance has been assigned a use. This information has been communicated to upstream suppliers

Improve efficiency/reduce safety risks for Engineering waste recycling

Additional facilities In place

EHS Refresher Training is provided for all employees of Penn Pharma

Utility consumption for 2008

UTILITY

UNITS / TURNOVER

Electricity (kWh)

Decrease by 12%

Gas (kWh)

Decrease by 1%

Water (M3)

Decrease by 31%

In Summary
Penn Pharma will ensure that it provides the necessary resources to ensure that the planned growth of the business is supported by solid foundation of ethical management, and as far as is reasonable practicable will strive to work towards a sustainable operational platform for its products and services.